Schematics for Streptamer staining. CTLs cytotoxic T lymphocytes. (TIFF 2289 kb

Jeetendra Kumar

Lalita Limaye

Vaijayanti Kale

Jeetendra Kumar (698117)

Vaijayanti Kale (698119)

Lalita Limaye (698120)

The Francis Crick Institute

Additional file 3: Figure S3. of Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy

Springer - Publisher Connector

Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy

Flow chart depicting experiment design for generation of dendritic cells (DCs). UCB umbilical cord blood, MNC mononuclear cells, GM-CSF granulocyte-macrophage colony stimulating factor, PBL peripheral blood, LPS lipopolysaccharide. (TIFF 2506 kb

Additional file 1: Figure S1. of Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy

Flow chart depicting experiment design for generation of cytotoxic T lymphocytes (CTL). UCB umbilical cord blood, PBL peripheral blood, LPS lipopolysaccharide, DC dendritic cells. (TIFF 3354 kb

Additional file 2: Figure S2. of Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy

Depicts the interaction of pulsed dendritic cells (DCs) and naïve T cells. A Clonal expansion of naïve T cells during co-culture with pulsed DCs. B Larger magnification to show the tethering of many naïve T cells with a mature DC. C Negligible interaction of unpulsed cytotoxic T lymphocytes (CTLs) with the target MCF-7 cells. D, E Flocking of CTLs derived from pulsed peripheral blood (PBL)/umbilical cord blood (UCB) DCs to the target MCF-7 cells. (TIFF 2950 kb

Additional file 4: Figure S4. of Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy

https://figshare.com/articles/Additional_file_3_Figure_S3_of_Umbilical_cord_blood-derived_CD11c_dendritic_cells_could_serve_as_an_alternative_allogeneic_source_of_dendritic_cells_for_cancer_immunotherapy/4475711

Umbilical cord blood-derived CD11c+ dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy

Abstract

Similar works

Full text

Available Versions

The Francis Crick Institute

Springer - Publisher Connector

The Francis Crick Institute

The Francis Crick Institute

The Francis Crick Institute

Springer - Publisher Connector